NEON Share Price Performance
CA$0
0.00 (0.00%)
Price CA$0
Share Pricen/a
No recently updated narratives available.
NeonMind Biosciences Inc. engages in the drug development of psychedelic compounds in Canada. It operates in two divisions, Pharmaceutical and Medical Services. The company’s lead product candidate is the NEO-001, a high-dose psilocybin for the treatment of obesity. It is also developing NEO-002, a low-dose psilocybin for the treatment of obesity. The company was formerly known as Flourish Mushroom Labs Inc. and changed its name to NeonMind Biosciences Inc. in April 2020. NeonMind Biosciences Inc. was incorporated in 2019 and is based in Oakville, Canada.